Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04015349
Other study ID # FUPelotas5
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2017
Est. completion date February 1, 2018

Study information

Verified date July 2019
Source Federal University of Pelotas
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This cross-sectional study will evaluate the association between sociodemographic, occupational, clinical conditions, psychological (sense of coherence), sleep quality variables and SB diagnosed by PSG, the gold standard exam with audio-visual resources obtained at Pelotas Sleep Institute.


Description:

Sleep bruxism is defined as a masticatory muscle activity during sleep that is characterised as rhythmic (phasic) or non-rhythmic (tonic) and should be considered a risk factor rather than a disorder in otherwise healthy individuals.

The diagnosis of sleep bruxism often is challenging and despite the use of questionnaires, clinical exams and portable devices, based on current knowledge, the polysomnography with audio-video recordings emerges as the gold-standard criteria for a definite sleep bruxism diagnosis.

Included on the questionnaire there is a registration form, which contains: included: age at time of data collection , gender, marital status , and education level ; Occupational: individuals were asked about work outside home, and working hours; Clinical condition: body mass index, smoking; alcohol consumption; use of sleeping pills; respiratory allergy and Psychological: sense of coherence .


Recruitment information / eligibility

Status Completed
Enrollment 240
Est. completion date February 1, 2018
Est. primary completion date November 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria:

- All adults (aged 20 to 60 years) and elderly (aged >60 years)

Exclusion Criteria:

- Inadequate cognitive capacity to understand and answer the questionnaires;

- Degraded PSG image quality;

- Questionnaires filled incorrectly;

- Participants who presented a history of epilepsy that could interfere in the results of polysomnography.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Polysomnography
The polysomnography (referred to as type I) allows assessing several sleep physiologic parameters (eg, EEG, electrooculogram, electromyogram, electrocardiogram, airflow, respiratory effort, oxygen saturation), whereas audio-video recording enables documenting tooth-grinding sounds and distinguishing between rhythmic masticatory muscle activity (RMMA) and orofacial (eg, swallowing) and other muscular activity (eg, head movements) during sleep. Based on the RMMA index (number of episodes per hour of sleep), sleep bruxism is diagnosed when RMMA episodes are greater than or equal to 2 (low-frequency SB, mild bruxism) or RMMA episodes are greater than or equal to 4 (high-frequency SB, severe bruxism)

Locations

Country Name City State
Brazil Federal University of Pelotas Pelotas RS

Sponsors (1)

Lead Sponsor Collaborator
Federal University of Pelotas

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patients with Sleep Bruxism by Polysomnography exams The data were obtained from polysomnography records in which masseter electromyography (EMG) burst was detected based on a predefined EMG threshold (20% of maximal voluntary tooth clenching task). Right masseter EMG bursts exceeding 0.25 second in duration were selected for oromotor activity scoring according to published criteria. Oromotor episodes separated by 3-second intervals were recognized as rhythmic masticatory muscle activity (RMMA) if they corresponded to 1 of the 3 following patterns: phasic (3 or more EMG bursts, each lasting 0.25 to 2 seconds), tonic (1 EMG burst lasting more than 2 seconds), or mixed (both burst types) episodes. EMG bursts were considered within the same RMMA episode if the interval between them was shorter than 2 seconds. Participants had SB diagnosed by polysomnography (PSG) if the RMMA index was greater than 2 episodes per hour of sleep. 4 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04792398 - Bruxism Xeomin® Intervention Trial Phase 4
Completed NCT03825237 - Sleep Architecture and Factors Associated With Definitive Diagnosis of Sleep Bruxism
Completed NCT04934449 - Occlusal Splints in the Treatment of Sleep Bruxism N/A